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a b s t r a c t
Xenopus laevis is among the few species that are capable of fully regenerating a lost lens de novo. This
occurs upon removal of the lens, when secreted factors from the retina are permitted to reach the cornea
epithelium and trigger it to form a new lens. Although many studies have investigated the retinal factors
that initiate lens regeneration, relatively little is known about what factors support this process and
make the cornea competent to form a lens. We presently investigate the role of Retinoic acid (RA)
signaling in lens regeneration in Xenopus. RA is a highly important morphogen during vertebrate
development, including the development of various eye tissues, and has been previously implicated in
several regenerative processes as well. For instance, Wolfﬁan lens regeneration in the newt requires
active RA signaling. In contrast, we provide evidence here that lens regeneration in Xenopus actually
depends on the attenuation of RA signaling, which is regulated by the RA-degrading enzyme CYP26.
Using RT-PCR we examined the expression of RA synthesis and metabolism related genes within ocular
tissues. We found expression of aldh1a1, aldh1a2, and aldh1a3, as well as cyp26a1 and cyp26b1 in both
normal and regenerating corneal tissue. On the other hand, cyp26c1 does not appear to be expressed in
either control or regenerating corneas, but it is expressed in the lens. Additionally in the lens, we found
expression of aldh1a1 and aldh1a2, but not aldh1a3. Using an inhibitor of CYP26, and separately using
exogenous retinoids, as well as RA signaling inhibitors, we demonstrate that CYP26 activity is necessary
for lens regeneration to occur. We also ﬁnd using phosphorylated Histone H3 labeling that CYP26
antagonism reduces cell proliferation in the cornea, and using qPCR we ﬁnd that exogenous retinoids
alter the expression of putative corneal stem cell markers. Furthermore, the Xenopus cornea is composed
of an outer layer and inner basal epithelium, as well as a deeper ﬁbrillar layer sparsely populated with
cells. We employed antibody staining to visualize the localization of CYP26A, CYP26B, and RALDH1
within these corneal layers. Immunohistochemical staining of these enzymes revealed that all 3 proteins
are expressed in both the outer and basal layers. CYP26A appears to be unique in also being present in
the deeper ﬁbrillar layer, which may contain cornea stem cells. This study reveals a clear molecular
difference between newt and Xenopus lens regeneration, and it implicates CYP26 in the latter
regenerative process.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Although mammals have a rather limited ability to regenerate
lost or damaged tissues, other metazoans exhibit the remarkable
capacity to regenerate a variety of tissues, including intact organs.
De novo regeneration of the lens has been reported in newts,
salamanders, a ﬁsh, and frogs of the genus Xenopus (Freeman,
1963; Henry, 2003). Upon removal of the lens, the outer cornea
becomes exposed to molecular factors in the vitreous humor that
are secreted by the retina, and these factors induce the cornea to
form a new lens. The exact identities of these factors are not clear,
but Fibroblast Growth Factors (FGFs) have been implicated as both
necessary (Fukui and Henry, 2011) and sufﬁcient (Bosco et al.,
1997) for lens regeneration to occur. Additionally, Bone Morpho-
genic Proteins (BMP) signaling has been shown to be critical for
lens regeneration in Xenopus (Day and Beck, 2011). However, the
molecular factors that support this process and make the cornea
competent to respond to these retinal factors are much less
understood.
All-trans Retinoic Acid (RA) plays various roles in the develop-
ment of ocular tissues. Morphogenesis of the eye, as well as the
development of the retina, lens, and cornea, have all been shown
to be orchestrated by RA signaling (Enwright and Grainger, 2000;
Hyatt et al., 1996b; Kastner et al., 1994; Molotkov et al., 2006;
Wagner et al., 2000). RA signaling has been implicated in the
process of vertebrate lens regeneration as well, when Tsonis and
colleagues found evidence that RA signaling is necessary for lens
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regeneration in the newt (Tsonis et al., 2000; Tsonis et al., 2002).
In the case of newts and salamanders, lens regeneration occurs via
transdifferentiation of the dorsal pigmented iris epithelium.
Remarkably, the ventral iris of the newt, which is normally
incapable of regenerating a lens, can also give rise to lens cells
when they are made to express six3 in the presence of exogenous
RA (Grogg et al., 2005). Although the process of lens regeneration
in Xenopus has traditionally been described as involving transdif-
ferentiation of the differentiated cornea epithelium, recent studies
suggest that a population of multipotent corneal stem cells or their
transient amplifying progeny may be the source of the regenerated
lens (Perry et al., 2013). Previously, we identiﬁed a speciﬁc nuclear
receptor involved in RA-signaling (rxrg) in a subtracted cDNA
library representing genes upregulated in the cornea during
Xenopus lens regeneration (Malloch et al., 2009). The collective
data seems to indicate an important role for RA signaling in tissues
that regenerate a lens.
The biological source of retinoids in animals is dietary Vitamin
A (retinol). Once inside the cell, retinol can be oxidized to
retinaldehyde by retinol dehydrogenase enzymes (RDH), and
further oxidized into RA by retinaldehyde dehydrogenases
(RALDH). RA effects its inﬂuence on the cell by binding to Retinoic
Acid Receptors (RARα/β/γ) and Retinoid X Receptors (RXRα/β/γ),
that can homo- or heterodimerize in limited combinations to bind
to speciﬁc DNA motifs in the genome known as Retinoic Acid
Response Elements (RAREs) (reviewed by Bastien and Rochette-
Egly, 2004). The RA nuclear receptors can act as either transcrip-
tional repressors, or transcriptional activators in different contexts.
Moreover, RA can exert its inﬂuence at different locations than
where it was produced, by binding to Cellular Retinoic Acid
Binding Protein (CRABP) and being transported out of these cells.
Thus, RA can act as both an autocrine and paracrine signal.
A cytochrome P450 superfamily enzyme, CYP26, metabolizes RA
within the cell and thereby regulates RA levels in a time and tissue
speciﬁc manner (Cvekl and Wang, 2009; Niederreither and Dolle,
2008). Careful coordination of RA synthesis and metabolism
establishes cell or tissue-speciﬁc patterns of RA signaling within
an animal (Duester, 2008; Rhinn and Dolle, 2012). The activity of
CYP26 is important for proper embryonic development by estab-
lishing boundaries of RA signaling. CYP26 is highly expressed in
the lens epithelium of Xenopus embryos, suggesting a necessity of
RA signaling ablation in those cells (Hollemann et al., 1998),
although the reason for that is presently unclear.
Although RA has been implicated in the process of lens regen-
eration in newts, its role in Xenopus cornea-lens regeneration is not
understood. In the present study we implicate RA metabolism
mediated through CYP26 as a necessary event for lens regeneration
to occur in Xenopus, using a pharmacological inhibitor of CYP26, as
well as exogenous RA, and a synthetic retinoid, TTNPB. Further, we
examine the effects of these compounds on cell proliferation, and
expression of putative stem cell markers. We also characterize the
localization of RALDH and CYP26 proteins within the cornea.
Materials and methods
Animals
Xenopus laevis adult frogs were acquired from Nasco (Fort
Atkinson, WI). X. laevis embryos and larvae were raised following
Henry and Grainger (1987), and Henry and Mittleman (1995). All
staging is according to Niewkoop and Faber (1956).
Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis
X. laevis larvae of stages 48–50 were anesthetized in 1:2000 MS-
222 (Sigma, St. Louis, MO) diluted in 1/20 Normal Amphibian Media
(NAM; Slack, 1984). Corneas were excised with ﬁne iridectomy
scissors and ﬂash-frozen in a dry ice/ethanol bath at 80 1C.
“Control” cornea tissue was obtained by collecting and freezing
corneas from unoperated animals. For “Regenerating” corneal
tissue, stage 48–50 tadpoles were lentectomized, and corneas from
the operated eyes were removed and collected at 1, 3, and 5 days
post-lentectomy, and pooled together for RNA extraction. RNA was
extracted from the samples by homogenization in TRIzol (Ambion,
Grand Island, NY) and processed using Direct-zol RNA MiniPrep
columns (Zymo Research, Irvine, CA). Each sample was then treated
with DNAse I (New England Bioloabs, Ipswich, MA) to remove any
possible genomic DNA contamination, and run through a NucAway
Spin column (Ambion, Austin, TX) to remove reaction contaminants.
cDNA was synthesized from the RNA using an iScript cDNA
synthesis kit (BioRad, Hercules, CA). Half of the RNA from each
sample was used for “-RT” control cDNA, which employed the
iScript cDNA synthesis kit, but with water in place of the supplied
reverse transcriptase enzyme. “Lens” RNA was obtained similarly,
from lenses isolated from stage 49–52 tadpoles. As a positive
control for all primer sets, “Embryonic” RNA was harvested simi-
larly, using pooled stage 1–33 embryos. PCRs were run in 50 ml
volumes for 30 rounds using 7 ng of input cDNA template. GAPDH
was used as a positive control for each sample of cDNA. Sequences
of primer pairs and the melting temperatures used for each are
listed in Supplementary Table 1. The identity of every PCR band was
conﬁrmed by DNA sequencing at the Roy J. Carver Biotechnology
Center (University of Illinois, Urbana, Illinois).
In vitro lens regeneration assay
The in vitro lens regeneration assays using pharmacological
inhibitors were performed as outlined in Fukui and Henry (2011),
with some variations. Brieﬂy, animals were anesthetized in 1:2000
MS-222 (Sigma, St. Louis, MO) diluted in 1/20 NAM. Incisions were
made using ﬁne iridectomy scissors in the outer cornea and the
lens was removed. The outer cornea was then tucked into the
empty vitreous chamber and the whole eye was then excised, and
placed into a well of a 24-well tissue culture plate. Eyes were
separately cultured for 7 days in 350 ml of modiﬁed L-15 media
(2:3 dilution of L-15 media, with 10% fetal bovine serum, 2.5 mg/ml
amphotericin, 10 kU/ml penicillin–streptomycin, and 4 mg/ml mar-
boﬂoxacin) supplemented with the appropriate concentration of
pharmacological compound or vehicle (DMSO). The following
6 experimental conditions were tested: 100 mM Liarozole Hydro-
chloride (Tocris, Bristol, UK), 20 mM TTNPB (Tocris), 1 mM all-trans
Retinoic acid (Sigma), 20 mM all-trans Retinoic acid, 60 mM Citral
(Sigma), and 5 mM LE-135 (Tocris). Culture media was changed
daily, and after 7 days of culture, eyes were rinsed brieﬂy with PBS
and ﬁxed in 3.7% formaldehyde for 2 h at 25 1C. Eyes were then
dehydrated in ethanol, later cleared with xylene, and subsequently
embedded in parafﬁn wax. Eyes were sectioned at a thickness of
9 mm and placed onto a positively charged microscope slide
(Colorfrost Plus, Thermo Scientiﬁc, Kalamazoo, MI) for immuno-
histochemical staining with a polyclonal anti-lens antibody (Henry
and Grainger, 1990). Imaging was done using a Zeiss Axioplan light
microscope. The presences of morphologically distinct lentoid
structures that positively stained with the antibody were scored
as successful cases of lens regeneration. Statistical signiﬁcance in
differences between regeneration rates was established using
(two-tailed) Fisher0s Exact test.
Quantitative RT-PCR (qPCR)
Corneas were cut around the periphery of the eye from stage
48–51 tadpoles, leaving the cornea epithelium attached to the eye
via the central corneal stalk. Then, the whole eye was excised from
the animal and placed into modiﬁed L-15 culture media containing
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an appropriate concentration of pharmacological compound or the
DMSO. The following conditions were tested: 100 mM Liarozole,
20 mM TTNPB, 1 mM all-trans Retinoic acid, 20 mM all-trans Retinoic
acid, with 0.2% DMSO as a control condition. Additionally we
tested 60 mM Citral and 5 mM LE-135, with 0.05% DMSO as a
control condition. For each condition, 20–25 eyes were cultured
together in small petridishes containing 3 ml of culture media.
After 4 days of culture the corneas were surgically removed from
each eye and placed into a microcentrifuge tube immersed in
ethanol and dry ice, as described above. RNA was extracted and
processed from each pool of corneas and cDNA was generated in
the same manner as described above.
All qPCR experiments were performed 3–4 times, with techni-
cal replicates receiving 10–25 ng of input cDNA. SYBR Green
reagent (kindly provided by Dr. Jie Chen, University of Illinois at
Urbana-Champaign) was used along with 125 nM of forward
primers and 500 nM of reverse primers for actb and cyp26a1,
and 500 nM of both primers for sox2, oct60, and p63. All primers
are listed in Supplementary Table 1. actb (beta-actin) Was used as
the internal control gene in every experiment, and the expression
of the test gene under each drug-treated condition was normal-
ized to the expression of that same gene in the control condition.
Melting-curve analysis was conducted for each experiment. Fold
changes of expression were determined using the comparative CT
method (Schmittgen and Livak, 2008). Statistical signiﬁcance was
established using the (unpaired) t test.
Immunohistochemistry
Stage 50–51 animals were ﬁxed in 3.7% formaldehyde for
30 min at 25 1C. Whole eyes were then excised and processed
with the cornea still attached at the corneal stalk. All steps of
processing were done in a 1 PBS buffer with 0.2% Triton X-100.
Eyes were blocked in a solution of 5% bovine serum albumin and
5% normal goat serum. All primary antibody incubations were
done overnight at 4 1C, and secondary antibody incubations were
1–2 h at 25 1C. Primary antibodies included polyclonal rabbit-anti-
CYP26A (1:200 dilution; Abcam, Cambridge, MA), polyclonal
rabbit-anti-CYP26B (1:100 dilution; Abcam), and polyclonal
mouse-anti-RALDH1 (1:200 dilution; Abcam). Western blot
analysis using cornea and embryonic protein extracts revealed
appropriately sized bands for each of these antibodies (Fig. S1).
The following secondary antibodies were used: Alexa Fluor 488
goat-anti-mouse, and Alexa Fluor 488 goat-anti-rabbit (1:500
dilution; Life Technologies, Grand Island, NY). Cell boundaries
were visualized with the addition of 1:150 rhodamine-
conjugated phalloidin (Cytoskeleton, Denver, CO), added sepa-
rately after secondary antibody incubation, overnight at 4 1C.
Nuclei were visualized by staining the tissue in DAPI for 15 min
at 25 1C (1 mM; Sigma, St.Louis, MO). After processing, the corneas
were gently lifted off of the eyes using ﬁne forceps and were
placed into a drop of mounting media (ProLong Gold; Invitrogen,
Eugene, OR) placed on charged slides (Colorfrost Plus, Thermo
Scientiﬁc, Kalamazoo, MI). A coverslip was then placed on top of
each cornea, and pressed downward to ﬂatten the tissue before
being left to cure overnight at 25 1C. Imaging was done on a Zeiss
LSM-700 confocal microscope.
Measuring cell division with phospho-histone H3 staining
Corneas were cut around the periphery of the eye from stage
48–50 tadpoles, leaving the cornea epithelium attached to the eye
via the central corneal stalk. Then, the whole eye was excised from
the animal and placed into modiﬁed L-15 culture media containing
an appropriate concentration of pharmacological compound or
DMSO. The following conditions were tested: 100 mM Liarozole,
20 mM TTNPB, 1 mM all-trans Retinoic acid, 20 mM all-trans Retinoic
acid, with 0.2% DMSO as a control condition. 3–4 Eyes at a time
were cultured in 1 mL of culture media. After 4 days of culture, the
eyes were rinsed brieﬂy in PBS, ﬁxed in 3.7% formaldehyde for 2 h,
and stained using rabbit anti-phospho-Histone H3 (1:200 dilution;
kindly provided by Dr. Craig Mizzen, University of Illinois at
Urbana-Champaign) in the same manner described above, with
two modiﬁcations: nuclei were visualized by staining with
Hoechst (1:10,000 dilution; Molecular Probes, Eugene, OR) for
20 min, and imaging was done on a Zeiss Axioplan microscope.
Quantiﬁcation of cell division was performed by ﬁrst sampling
a standardized square area within the cornea in each image to
measure the nuclear density of that cornea. Then, the total number
of nuclei in each cornea was determined by multiplying the
calculated nuclear density by the total area of that cornea, as
measured using ImageJ (U.S. National Institutes of Health,
Bethesda, MD). Total number of mitotic ﬁgures in each cornea
was counted manually. The total number of mitotic ﬁgures per 100
nuclei (MFN) was used as a measure of cell division. The MFN was
determined for each individual case, and the mean MFN was
calculated for every experimental condition. Pericorneal tissue was
excluded from the analysis. Statistical signiﬁcance was established
using the (unpaired) t test.
Results
Expression of RA regulation related transcripts in Xenopus eye tissues
RT-PCR was performed to examine the expression of the
transcripts of aldh1a1/2/3, which encode the enzyme that acts in
the ﬁnal step of endogenous RA synthesis, and the point at which
tissue-speciﬁc patterning of an RA presence is generally regulated
(see review by Niederreither and Dolle, 2008). We also examined
transcripts of cyp26a/b/c1, which metabolize endogenous RA
(White et al., 1996). The expression of these members of RA
biosynthesis and metabolism allow one to infer changes in the
regulation of RA signaling within a given tissue. Three isotypes
exist for both enzymes in Xenopus, encoded by 6 distinct genes, so
primers were designed to examine all 6 independently. aldh1a1,
aldh1a2, and aldh1a3 (encoding RALDH1, RALDH2, and RALDH3
respectively) are all expressed in “Control” corneas harvested from
unlentectomized eyes, as well as “Regenerating” corneas collected
and pooled from 1, 3, and 5 days post-lentectomy (Fig. 1A).
cyp26a1 And cyp26b1 (encoding CYP26A and CYP26B, respec-
tively), but not cyp26c1 (CYP26C), are expressed in the cornea in
both control and regenerating tissues. The expression of these
genes was also examined in harvested lenses, where all of the
genes except aldh1a3 were found to be expressed (Fig. 1B).
RA signaling activation via CYP26 inhibition or application of
exogenous retinoids can both inhibit lens regeneration
In order to investigate the necessity of RA regulation by CYP26,
lentectomized eyecups were cultured in the presence of various
inhibitors and activators in an in vitro culture system described in
Fukui and Henry (2011). Eyes were cultured in the presence of
100 mM Liarozole Hydrochloride, an antagonist of CYP26. Treat-
ment with Liarozole profoundly inhibited lens regeneration
(po0.0001). Only 1/23 (4%) eyes regenerated a lens in the drug-
treated condition, compared to 13/20 (65%) with DMSO (Fig. 2A,
Fig. 3A–D). This result strongly implicates a necessary role for
CYP26 activity within the eye, suggesting that RA levels need to be
reduced in the cornea for lens formation to occur.
To assess whether the diminished regeneration is the result of
CYP26 antagonism, we cultured the eyecups with TTNPB, a potent
retinoic acid analog (Minucci et al., 1996; Pignatello et al., 1999),
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which is highly resistant to the metabolizing action of CYP26
(Pignatello et al., 2002). Since the molecular consequence of CYP26
antagonism should lead to a rise of endogenous RA, we assessed
whether the addition of CYP26-resistant TTNPB could impart the
same consequence on regeneration as Liarozole. Results show that
treatment of eyes with 20 mM TTNPB greatly reduced lens
Fig. 1. Expression of RA signaling related genes. (A) Expression of RA-signaling related genes in control corneas ("C") and pooled regenerating corneas from 1, 3, and 5 days
post-lentectomy ("R"). “þRT” group indicates reactions that employed reverse transcriptase for generation of cDNA. “–RT” group indicates reactions that used water in place
of reverse transcriptase, as a control for genomic contamination. “þ” indicates a positive control reaction performed using embryonic RNA. (B) Expression of genes in control
lenses.
Fig. 2. RA signaling inhibits lens regeneration, and RA signaling antagonism does not inhibit lens regeneration. (A) Liarozole and TTNPB are potent inhibitors of cornea-lens
regeneration. A high concentration of RA very strongly inhibits lens regeneration. n indicates po0.0001, using two-tailed Fischer0s exact test. (B) A drug-treatment validation
assay using qPCR shows that all of the drugs strongly activate RA signaling, as seen by a profound upregulation of cyp26a1, a marker of active RA signaling, in the cornea. n
indicates po0.01, using unpaired t test. (C) Citral and LE-135, inhibitors of RA signaling, fail to inhibit cornea-lens regeneration. (D) A drug-treatment validation assay using
qPCR shows that LE-135 attenuates expression of cyp26a1 in the cornea. n indicates po0.0001, using unpaired t test. All error bars indicate standard error.
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regeneration (po0.0001) as only 4/35 (11%) eyes regenerated
lenses, compared to 22/32 (69%) with DMSO (Fig. 2A, Fig. 3E-H).
We likewise examined whether exogenous RA would inhibit
regeneration. A relatively low concentration (1 mM) of RA failed
to do so, as 21/30 (70%) treated eyes regenerated, compared with
17/29 (59%) DMSO-treated eyes. The apparent slight increase in
Fig. 3. Lens regeneration assays. Representative examples are shown of positive cases of lens regeneration for each condition tested, with the exception of 20 mM RA, for
which no lenses regenerated. Panels (A, E, I, M, Q, U, C, G, K, O, S, and W) are images taken with a DIC microscope. Panels (B, F, J, N, R, V, D, H, L, P, T, and X) are images of
ﬂuorescently labeled lenses with an anti-lens antibody (red). Arrowheads indicate the regenerated lens. Scale bar in X¼100 mM.
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regeneration is notably not statistically signiﬁcant (p¼0.40).
However, a higher concentration (20 mM) of RA very strongly
inhibited lens regeneration, as 0/33 (0%) eyes regenerated when
treated with 20 mM RA, compared to 18/33 (55%) of eyes treated
with DMSO (po0.0001) (Fig. 2A, Fig. 3I–P).
To demonstrate that Liarozole and retinoid treatments were
actually affecting the RA signaling pathway, we performed a drug-
treatment validation assay to examine the expression of cyp26a1.
Cyp26 genes are known to respond robustly to Retinoic acid (de
Roos et al., 1999; Hollemann et al., 1998; Pavez Loriè et al., 2009),
so we checked for overexpression of cyp26a1 in drug-treated
tissue samples to conﬁrm activation of RA signaling. qPCR was
performed using RNA extracted from corneas that were treated
with either drug or vehicle for 4 days. All compounds used showed
a marked increase in cyp26a1 expression, as Liarozole-treated
corneas had 100-fold increase (p¼0.0007), and TTNPB had over
1000-fold increase (p¼0.0005) compared to control corneas.
Additionally, both 1 mM and 20 mM RA treatments showed over
1000-fold increase in cyp26a1 expression (p¼0.001 and p¼0.008,
respectively). There was no statistically signiﬁcant difference in
the expression levels between 1 mM and 20 mM RA (Fig. 2B). This
result demonstrates that all of the drug treatments have an
ultimate molecular consequence of increasing retinoid signaling
within the cornea. This increase in RA signaling is correlated above
with a failure to regenerate lenses from the cornea epithelium,
with the exception of 1 mM RA, which despite the increase in RA
signaling does not inhibit lens regeneration. This shows that while
cyp26a1 over-expression is a positive readout of increased RA
signaling and drug treatment efﬁcacy, elevated expression of
cyp26a1 does not in itself inhibit lens regeneration.
We also treated cases with inhibitors of RA-signaling. Treat-
ment with 60 mM Citral, an inhibitor of RA synthesis, did not
inhibit lens regeneration (p¼0.44), as 12/18 (64%) of Citral-treated
eyes regenerated compared to 15/18 (83%) of eyes treated with
vehicle alone. Likewise, 5 mM of LE-135, an antagonist of the RA
nuclear receptors RARα and RARβ, failed to inhibit lens regenera-
tion (p¼0.48), as 19/24 (79%) LE-135-treated eyes regenerated
lenses, compared to 12/18 (66%) of those treated with DMSO
(Fig. 2C, Fig. 3Q–X). These results are consistent with our hypoth-
esis and suggest that antagonism of RA signaling does not prevent
lens regeneration from occurring in the eye.
Additionally we assessed whether these compounds acted
upon the RA signaling pathway using qPCR. Corneas treated with
LE-135 expressed only half as much cyp26a1 compared to controls
(po0.0001). This suggests that RA-receptor antagonism does not
itself lead to a decrease in lens regeneration. However, cyp26a1
expression was unaffected for Citral-treated corneas (Fig. 2D).
The effect of CYP26 inhibition and exogenous retinoids on cell
proliferation in the cornea
We examined the effects of Liarozole, TTNPB, and RA upon cell
division corneas by culturing them in the presence of the compounds
in vitro for 4 days and measuring cellular division. Phosphorylated
Histone H3 is a reliable marker of cell division (Hans and Dimitrov,
2001), so we used an α-phospho-Histone H3 antibody to visualize
and count mitotic cells in the corneas. The metric we used in
quantifying changes in cell division was to measure the number of
Mitotic Figures for every 100 Nuclei in the cornea (MFN), which
allows us to control for the variation in nuclear density and number
across individual corneas. Corneas cultured with DMSO had a mean
MFN of 1.9 (n¼9), and no statistically signiﬁcant difference was
measured for treatment with TTNPB (mean MFN¼1.44; n¼7), 1 mM
RA (mean MFN¼¼1.66; n¼8), or 20 mM RA (mean MFN¼1.45;
n¼6) (Fig. 4). Treatment with Liarozole however reduced cell
Fig. 4. The effect of CYP26 inhibition, and exogenous retinoids on cell proliferation in the cornea. Nuclei are labeled with Hoechst (blue) and mitotic cells are labeled with anti-
phospho-Histone H3 antibody (green). When compared to treatment with DMSO in vitro (A), treatment with TTNPB (C), 1 mM RA (D), or 20 mM RA (E) has no effect on the
number of mitotic cells at in the cornea. Treatment with Liarozole (B) reduced cell division. White arrowheads indicate examples of mitotic ﬁgures found in the cornea. Note
that not every mitotic ﬁgure is pointed out in (A) and (E). The white dotted outline demarcates the cornea proper from pericorneal epithelium. The results are quantiﬁed in
(F). Error bars show standard error. n indicates po0.0001 using unpaired t-test. Scale bar in E¼50 mm.
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division in half (mean MFN¼0.89; n¼9; po0.0001). Since only
Liarozole treatment, and not exogenous retinoids, resulted in a
reduction of cell division, the decrease in cell division is not due to
the rise in endogenous RA that results from CYP26 antagonism.
Moreover, a reduction in cell division does not necessarily result from
altered RA levels.
The effect of CYP26 inhibition and exogenous retinoids on the
expression of putative stem cell markers
We performed qPCR to assess whether the expression of
3 putative corneal stem cell markers—sox2, oct60, and p63 (Perry
et al., 2013)—was affected by the drug treatments in vitro. A small
increase in expression was observed for sox2 when corneas were
treated with TTNPB (3-fold; po0.0001), 1 mM RA (2.75-fold;
po0.0001), and 20 mM RA (2.15-fold; po0.0001). Liarozole treat-
ment did not affect the expression of sox2. The expression of oct60
decreased with 1 mM RA (0.6-fold; p¼0.02) and 20 mM RA
(0.45-fold; p¼0.0007). Neither Liarozole nor TTNPB affected the
expression of oct60. The expression of p63 decreased with 1 mM RA
(0.6-fold; p¼0.002) and 20 mM RA (0.4-fold; po0.0001). Neither
Liarozole nor TTNPB affected the expression of p63 (Fig. 5). Since
Liarozole inhibited lens regeneration but did not affect the
expression of any of these 3 genes, and 1 mM RA did not inhibit
regeneration but did affect the expression of all 3 genes, it appears
that the impact of altered RA signaling on lens regeneration is not
directly related to the expression of these 3 genes in the cornea.
Fig. 5. qPCR of putative corneal stem cell markers. Corneas cultured in vitro in the
presence of retinoids show upregulation of sox2, and downregulation of oct60 and
p63. CYP26 inhibition with Liarozole does not affect the expression of any of these
genes. Error bars show standard error. n indicates po0.05 and nn indicates po
0.001 using unpaired t-test.
Fig. 6. Cellular localization of CYP26 and RALDH enzymes in the cornea. Corneal whole-mount immunoﬂuorescence staining was used to visualize the expression of CYP26A
(A–C), CYP26B (D–F), and RALDH1 (G–I), in each of the 3 layers of the larval cornea—the outer epithelium (A, D, G), the basal layer (B, E, H), and the deeper ﬁbrillar layer
(C, F, I). CYP26A (green) is expressed in all layers, including the sparse cells of the ﬁbrillar layer (arrowheads). CYP26B (green) and RALDH1 (green) are only expressed in the
outer epithelial and basal layers, and are not seen in the cells of the ﬁbrillar layer (arrowheads). DAPI (blue), phalloidin (red). Scale bar in G¼20 mm.
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Localization of CYP26 and RALDH in the cornea epithelium
Since CYP26 function appeared to be necessary for lens
regeneration, we next examined the possible sites of RA metabo-
lism with immunohistochemical staining of CYP26. We recently
described that the Xenopus cornea is constructed of 3 distinctly
identiﬁable layers of cells (Perry et al., 2013), so we employed
whole mount immunohistochemical staining of cornea pelts and
confocal microscopy to visualize subcellular localization of pro-
teins within corneal tissue.
Staining with α-CYP26A antibody revealed CYP26A localization
in both the outer and basal layers of the cornea epithelium
(Fig. 6A,B). Furthermore, staining was seen in the sparse cells of
a deeper ﬁbrillar layer that lies beneath the basal epithelium
(Fig. 6C, arrowheads). In contrast, use of an α-CYP26B polyclonal
antibody showed that CYP26B does not localize to the cells of the
ﬁbrillar layer (Fig. 6F, arrowheads) although it does stain the other
two cellular layers (Fig. 6D,E).
Finally we examined the possible site of RA synthesis within
the cornea using an α-RALDH1 antibody. Staining revealed
RALDH1 localization in cells of the outer, and basal layers, but
not the ﬁbrillar layers of cells, in a pattern that was highly similar
to that of CYP26B (Fig. 6G–I).
Discussion
Much of what is currently known about the roles of RA
signaling in the development of the vertebrate eye comes from
expression analyses and knockout experiments in mouse embryos
(Cvekl and Wang, 2009; Duester, 2008; Ross et al., 2000). In
Xenopus, RA affects eye ﬁeld and telencephalon ﬁeld development
and has a stronger inﬂuence on the ventral aspect of these ﬁelds
(Eagleson et al., 2001). Regions of RA signaling activity also
coincide with regions of Pax6 expression, and Pax6-mutant tissues
exhibit defective retinoid production. Mice with mutated Pax6
have reduced RA signaling in the developing eye, with particularly
serious effects in the lens (Enwright and Grainger, 2000), and RA
induces the expression of αB-Crystallin, a marker of murine lens
cells, in vitro (Gopal-Srivastava et al., 1998).
In Xenopus, it is known that RA, FGF receptor, and Hedgehog
signaling pathways all serve to ventralize the developing eye (Lupo
et al., 2005). Later in development, the mouse retina has dorsal
and ventral zones rich with RA, with a horizontal band of RA-poor
cells, all established via coordinated expression of RALDH and
CYP26 enzymes (Sakai et al., 2004; Wagner et al., 2000). RA
signaling components, including Raldh and Cyp26 genes, are
expressed throughout the embryo during Xenopus organogenesis
(Lynch et al., 2011).
RA signaling has been implicated in the regeneration of several
tissues as well. The application of Disulﬁram, another RA synthesis
inhibitor, inhibits the regeneration of tadpole tails in Xenopus as
well as limbs in axolotls (Maden, 1998). Application of retinoids
such as Vitamin A or TTNPB cause fully formed limbs to sprout in
place of a tail in Rana temporaria (Maden and Corcoran, 1996).
Similarly, application of Vitamin A and RA both result in duplica-
tions of limbs when applied during the course of limb regenera-
tion in axolotls (Maden, 1983). In our own lab we have observed
that Disulﬁram fails to inhibit lens regeneration when live,
lentectomized Xenopus tadpoles are kept in water containing an
even higher concentration (10 mM) of the compound than what
was used in the above studies (data not shown). Here we report
that RA synthesis inhibition via Citral has the same null effect on
lens regeneration in vitro. Likewise, treatment with another RA
inhibitor, LE-135, also did not affect lens regeneration (Fig. 2C).
Lens regeneration in newts (Wolfﬁan lens regeneration) occurs
via transdifferentiation of the dorsal iris pigmented epithelial cells,
following exposure to factors provided by the retina (Tsonis et al.,
2004). RA signaling has been established as a necessary signaling
scheme during this process, as application of a RARα inhibitor
greatly reduced the regenerative potential of the dorsal iris, and
application of a pan-RAR antagonist greatly inhibited regeneration
and sometimes caused ectopic lens formation following lens
removal. In one case, a lens regenerated from the cornea instead
of the dorsal iris, corroborating our ﬁnding here that RA signaling
attenuation is supportive of lens regeneration from the cornea.
Moreover, addition of exogenous retinoids had no effect on newt
lens regeneration (Tsonis et al., 2000, 2002). The importance of RA
in Wolfﬁan regeneration was further demonstrated when RA
treatment together with six3 expression transformed the normally
lens-incompetent ventral iris into lens regeneration-competent
tissue (Grogg et al., 2005). In contrast, the present study demon-
strates that active RA signaling is prohibitive for lens regeneration
in Xenopus.
RT-PCR data indicate that RALDH1-3 are all present in both
control and regenerating corneas. RALDH1 and RALDH2 are both
present in the lens, but RALDH3 is absent, suggesting that there
might be a reduced need for RA production in lens tissue. CYP26C
is also expressed in the lens, unlike control and regenerating
corneas, which express only CYP26A and CYP26B, and thus the
lens expresses all 3 RA-degrading enzymes (Fig. 1B). It is possible
that during the course of lens differentiation from corneal tissue, it
becomes necessary to reduce the rate of production of RA, and to
increase the removal of RA from these tissues, and this is
accomplished through regulated expression of the various RALDH
and CYP26 enzymes. Although CYP26C can bind and degrade
9-cis-RA, all-trans RA is its preferred substrate (Taimi et al.,
2004). In Xenopus embryos the developing lens expresses cyp26a1,
speciﬁcally within the lens epithelium, likely to moderate the
effects of RA in that region (Hollemann et al., 1998; Lynch et al.,
2011).
Here, immunohistochemical staining revealed the presence of
CYP26A and CYP26B in both the outer and basal layers of the
cornea epithelium (Fig. 6). The granular staining patterns observed
in these cells is characteristic of the known staining pattern of
endosome-localized cytochrome P450 enzymes in the cytoplasm
(Makwana et al., 2012; Yague et al., 2004). CYP26A and CYP26B
could act to eliminate an unwanted inﬂuence of RA in these cells.
CYP26A, unlike CYP26B, is also found in the cells of the ﬁbrillar
layer. Although the identity and function of these deeper cells is
not clear, they may be keratinocytes. Basal keratinocytes of human
skin express CYP26A, which carefully modulates the levels of skin
RA (Heise et al., 2006). Relative to CYP26B, CYP26A has signiﬁ-
cantly higher catalytic activity for metabolizing RA into the
metabolite 4-oxo-RA (Topletz et al., 2012). The presence of the
more highly active CYP26A enzyme in the cells of the ﬁbrillar layer
may highlight the urgency of RA disposal in those cells. This is
further corroborated by the inducibility of CYP26A by retinoid
treatments, as demonstrated through qPCR. Staining of retinoid-
treated corneas with anti-CYP26A1 antibody revealed no obvious
information as to whether any of the 3 cell layers in particular
were more highly responsive to retinoid treatments than the
others (data not shown).
Hyatt et al. (1996a) prevented the proper development of
photoreceptor cells in zebraﬁsh in vivo with the administration
of just 3 mM Citral. In our experiments, as much as 60 mM of Citral
had no effect on lens regeneration in vitro. It should be noted
however that qPCR data indicated that no decrease occurred in
the expression levels of cyp26a1 following Citral treatment,
suggesting the possibility that RA signaling may not have been
affected by that treatment. Citral is a competitive inhibitor of the
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dehydrogenase enzymes responsible for RA synthesis, and there
may have been enough RA present in the serum used in the
culture media to compensate for the presence of Citral. The usage
of LE-135 offers a better demonstration that inhibition of RA
signaling, speciﬁcally antagonism of RARα and RARβ, has no
consequences upon lens regeneration. cyp26a1 is strongly down-
regulated upon treatment with LE-135, indicating that RA signal-
ing has been negatively affected. These results stand in contrast to
what has been shown in Wolfﬁan regeneration. Liarozole is a well-
established inhibitor of RA metabolism (Pignatello et al., 2002;
Stoppie et al., 2000; Takeuchi et al., 2011), and is used clinically for
the treatment of skin diseases (Pavez Loriè et al., 2009). Liarozole
treatments profoundly inhibited lens regeneration, but our results
do not distinguish whether CYP26 acts strictly to clear RA from the
cornea, or if it is necessary to generate RA metabolites such as
4-oxo-RA. 4-oxo-RA is known to affect anterior-posterior (AP) axis
development in Xenopus (Pijnappel et al., 1993), but little else is
understood about the potential signaling role for this molecule in
other contexts. To corroborate the hypothesis that Liarozole
inhibited regeneration due to increased RA signaling that results
from the raising of endogenous RA levels, we also treated eyes
with TTNPB and all-trans RA, and saw the same effect. TTNPB has
been documented as a signiﬁcantly more potent retinoid than all-
trans RA, and is resistant to metabolism by CYP26 (Kistler et al.,
1990; Pignatello et al., 1997, 1999). Although TTNPB effectively
inhibited lens regeneration, we did not observe a signiﬁcantly
greater inhibition of regeneration with the use of TTNPB compared
to all-trans RA. cyp26a1 expression as examined by qPCR also did
not show a signiﬁcant increase of potency for TTNPB over RA.
Treatments with retinoids such as TTNPB are known to cause AP
axis defects during Xenopus development (Minucci et al., 1996).
We treated Xenopus gastrulas with the same concentrations of
retinoids used in the lens regeneration assays to observe axis
defects, and again found that TTNPB was not more potent than RA
for inducing defects (data not shown). Therefore, although the
reason for the lack of increased potency of TTNPB over all-trans RA
in our experiments is unclear, it is not likely that it is due to a
unique functional difference of TTNPB in the context of cornea-
lens regeneration.
Treatment with 1 mM RA did not have an effect on lens
regeneration, even though it greatly stimulated the expression of
cyp26a1, and 20 mM of RA both completely inhibited lens regen-
eration and stimulated cyp26a1 expression. This data suggests that
there is a limit to the RA-protective activity of CYP26 within these
tissues. cyp26a1 expression is simply an indicator of changes in RA
signaling activity and the data shows that its expression is not by
itself the cause of the inhibition of lens regeneration.
Cell proliferation occurs throughout the larval cornea epithe-
lium (Perry et al., 2013). Retinoic acid is an inducer of epithelial
cell proliferation (Kim et al., 2012; Nabeyrat et al., 1998; Wang
et al., 1997) and its popularity in pharmaceutical applications (as
Tretinoin) is partly derived from this property. Although it is not
yet clear whether the regenerated lens in Xenopus is derived from
transdifferentiated cornea cells, or multipotent cornea stem cells, a
ﬁnal phase of cellular differentiation is clearly necessary in the
course of generating a new lens de novo. We assessed whether the
presence of RA in corneal tissue may prevent proper differentia-
tion of cells due to changes cell proliferation. We cultured normal,
whole corneas in vitro in the presence of Liarozole or retinoids,
and examined cell division through immunohistochemical stain-
ing of phosphorylated Histone H3. Although our examination was
conﬁned to a single snapshot in time, we can nonetheless observe
the effects of these compounds on cell proliferation in control and
drug-treated corneal tissue. Interestingly, CYP26 inhibition via
Liarozole reduced cell proliferation in half, but treatment with
the retinoids did not have any measurable effect on proliferation
(Fig. 4F). This suggests that the inhibitory effect of Liarozole on cell
division is not likely due to rising levels of endogenous RA levels in
these tissues. Rather, it is possible that the metabolite generated
by CYP26, 4-oxo-RA, may be a regulator of cell division in the
cornea. The action of CYP26 therefore may be necessary as a
regulator of cell turnover, and by extension, an enabler of proper
differentiation into lens cells. It additionally seems that the
inhibitory effect of exogenous retinoids on lens regeneration is
not caused by depressed (or elevated) cellular division. This leaves
open the possibility that although decreased cell division is
coincident with Liarozole treatment, it may not itself be the cause
of inhibited lens regeneration. In fact, inhibiting cell proliferation
in the Xenopus cornea with Mitomycin C does not inhibit lens
regeneration (Filoni et al., 1995). Further experiments are neces-
sary to deﬁnitively conﬁrm the mechanistic roles and cytological
consequences of CYP26 action, and excess retinoids, during lens
regeneration.
We have recently provided evidence for a possible stem cell
identity for cells of the basal and ﬁbrillar layers (Perry et al., 2013),
and CYP26 may act to prevent the differentiating effects of RA in
order to maintain cellular multipotency. We tested this possibility
by treating corneas with drugs in vitro, to observe how it might
affect the expression of sox2, oct60, and p63, three putative stem
cell markers expressed within the cornea that are upregulated in
the early stages of lens regeneration. Most notably, CYP26 antag-
onism during tissue culture did not affect the expression of any of
these markers (Fig. 5), even though the antagonism was shown to
strongly inhibit lens regeneration (Fig. 2A). Interestingly, the
presence of 1 mM RA affected the expression of all 3 genes
(Fig. 5), although it does not affect lens regeneration (Fig. 2C).
Taken together, it appears that altering the expression levels of
these particular genes (to the modest degrees seen in our experi-
ments) is not related to lens regenerating competence in the
tissue. Notably, this does not provide evidence that the resident
stem cell population is irrelevant for lens regeneration. Indeed, the
cornea is composed of a heterogeneous cell population, and SOX2
and P63 localize to different subpopulations of cells (Perry et al.,
2013). Since it is not yet known which cells are important for lens
regeneration and which are important for corneal maintenance
and repair, it remains unclear whether and how CYP26 relates to
cellular multipotency or lens regenerating competence of the
cornea. It should be noted that it is not possible to reliably isolate
regenerating corneal tissue once it is inserted into the eyecup and
cultured in vitro. Therefore, we were unable to evaluate how the
expression of these genes might be affected following lens
removal, where the cornea is exposed to signaling factors from
the retina, in addition to the pharmacological compounds used in
this study. Regardless, it can be inferred from our data that
whatever role RA regulation plays to support cornea-lens regen-
eration, it is not likely via the modulation of sox2, oct60, and p63
transcription.
Considerable effort has been invested into understanding the
retinal factors that initiate the process of lens regeneration in
vertebrates, and FGF and FGFRs have emerged as important targets
of study (Bosco et al., 1997; Fukui and Henry, 2011). However, the
nature of the cornea that makes it competent to respond to those
retinal signals is poorly understood. pax6 expression is one factor
that has been associated with lens regeneration competence
(Gargioli et al., 2008). We presently provide evidence that RA
signaling must be attenuated within the cornea epithelium, which
could in part be responsible for endowing this tissue with lens-
forming competence. Additionally the present study presents for
the ﬁrst time a role for CYP26 in regeneration. It highlights an
important deviation fromWolfﬁan lens regeneration, and presents
a contrasting view to the regeneration-enabling role historically
attributed to Retinoic acid (Maden and Hind, 2003). The clear
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differences between Wolfﬁan and Xenopus regenerative processes,
as demonstrated here, underscore the importance of investigating
animal speciﬁc variations in regeneration of the same tissues, and
may reveal mechanisms that limit regenerative phenomena.
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